Nitric oxide inhibition of the rat olfactory cyclic nucleotide-gated cation channel.
The effects of nitric oxide (NO) and other cysteine modifying agents were examined on cyclic nucleotide-gated (CNG) cation channels from rat olfactory receptor neurons. The NO compounds, S-nitroso-cysteine (SNC) and 3-morpholino-sydnonomine (SIN-1), did not activate the channels when applied for up to 10 min. The cysteine alkylating agent, N-ethylmaleimide (NEM), and the oxidising agent, dithionitrobensoate (DTNB), were also without agonist efficacy. Neither SNC nor DTNB altered the cAMP sensitivity of the channels. However, 2-min applications of SIN-1, SNC and DTNB inhibited the cAMP-gated current to approximately 50% of the control current level. This inhibition showed no spontaneous reversal for 5 min but was completely reversed by a 2-min exposure to DTT. The presence of cAMP protected the channels against NO-induced inhibition. These results indicate that inhibition is caused by S-nitrosylation of neighboring sulfhydryl groups leading to sulfhydryl bond formation. This reaction is favored in the closed channel state. Since recombinantly expressed rat olfactory alpha and beta CNG channel homomers and alpha/beta heteromers are activated and not inhibited by cysteine modification, the results of this study imply the existence of a novel subunit or tightly bound factor which dominates the effect of cysteine modification in the native channels. As CNG channels provide a pathway for calcum influx, the results may also have important implications for the physiological role of NO in mammalian olfactory receptor neurons.
Department of Physiology and Pharmacology, University of Queensland, Brisbane, QLD, 4072, Australia.
J W
JW
Lynch
D000818:Animals; D000242:Cyclic AMP / Q000494:pharmacology / Q000502:physiology*; D054815:Cyclic Nucleotide-Gated Cation Channels; D003545:Cysteine / Q000031:analogs & derivatives* / Q000494:pharmacology; D004228:Dithionitrobenzoic Acid / Q000494:pharmacology; D004229:Dithiothreitol / Q000494:pharmacology; D005033:Ethylmaleimide / Q000494:pharmacology; D015640:Ion Channel Gating / Q000187:drug effects / Q000502:physiology; D007473:Ion Channels / Q000187:drug effects / Q000502:physiology*; D008981:Molsidomine / Q000031:analogs & derivatives* / Q000494:pharmacology; D020030:Nitric Oxide Donors / Q000494:pharmacology*; D009603:Nitroso Compounds / Q000494:pharmacology*; D018034:Olfactory Receptor Neurons / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D026403:S-Nitrosothiols; D013439:Sulfhydryl Reagents / Q000494:pharmacology
D054815:Cyclic Nucleotide-Gated Cation Channels; D007473:Ion Channels; D020030:Nitric Oxide Donors; D009603:Nitroso Compounds; D026403:S-Nitrosothiols; D013439:Sulfhydryl Reagents; C002385:linsidomine; C021315:S-nitrosocysteine; D004228:Dithionitrobenzoic Acid; D008981:Molsidomine; D000242:Cyclic AMP; D003545:Cysteine; D005033:Ethylmaleimide; D004229:Dithiothreitol